CD73 may also predict better response to PD-1/PD-L1 targeted therapy, as it is strongly associated with PD-L1 expression in gastrointestinal neuroendocrine tumors [86]. Here, CD274 is linked to digestive system neuroendocrine tumor, grade 1/2.